ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00784147
Brief Title: Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1 (TMB-202)

First Submitted : October 30, 2008
First Submitted that Met QC Criteria : October 30, 2008
First Posted : November 3, 2008 (Estimate)

Results First Submitted : March 11, 2014
Results First Submitted that Met QC Criteria : March 11, 2014
Results First Posted : April 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 17, 2014
Last Update Posted : May 5, 2014 (Estimate)